Repotrectinib potently and selectively inhibits the abnormally activated kinase signaling pathways of ROS1 and NTRK, effectively overcomes resistance mutations to conventional targeted therapies, and exhibits favorable central nervous system penetration.
Authentic
Guarantee
Fast Delivery
Privacy Copyright2024@ BIGBEAR All right reserved BIGBEAR



